OGN
Organon & Co
NYSE: OGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$13.33
-0.30% today
Updated 2026-06-05
Market cap
$3.53B
P/E ratio
14.45
P/S ratio
0.57x
EPS (TTM)
$0.93
Dividend yield
0.59%
52W range
$6 – $13
Volume
9.7M
Organon & Co (OGN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$13.33
12-Month target
$4.88
2030 Target
—
Intrinsic (DCF)
$12.46
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $6.3B | $6.2B | $6.3B | $6.4B | $6.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 14.45x (capped 25x) · Margin: 3.99%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.